Randeep will provide valuable assistance to the Group’s management team in delivering Tissue Regenix’s strategy to accelerate the development of a range of products based on its patented dCELL technology.
Tissue Regenix has announced the appointment of Randeep Singh Grewal as a non-executive director of the Group
Randeep will provide valuable assistance to the Group’s management team in delivering Tissue Regenix’s strategy to accelerate the development of a range of products based on its patented dCELL technology.
Tags
Related posts
- Cure Parkinson’s convenes expert panel to assess £2 million combination therapy funding call
- Kygevvi approved in Europe as first treatment for TK2d
- Tozorakimab shows significant benefit in two major COPD trials
- Daratumumab becomes first oncology injectable approved for patient administration
- Laigo Bio completes final close of €17m seed financing round
